BZYR — Burzynski Research Institute Income Statement
0.000.00%
- $4.22m
- $4.22m
Annual income statement for Burzynski Research Institute, fiscal year end - February 28th, USD millions except per share, conversion factor applied.
2021 February 28th | 2022 February 28th | 2023 February 28th | 2024 February 29th | 2025 February 28th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Total Operating Expenses | 1.3 | 0.977 | 0.916 | 1.34 | 1.39 |
| Operating Profit | -1.3 | -0.977 | -0.916 | -1.34 | -1.39 |
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -1.2 | -0.977 | -0.916 | -1.34 | -1.39 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -1.2 | -0.977 | -0.916 | -1.34 | -1.39 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -1.2 | -0.977 | -0.916 | -1.34 | -1.39 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -1.2 | -0.977 | -0.916 | -1.34 | -1.39 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.009 | -0.007 | -0.007 | -0.01 | -0.011 |